GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer

Published:2016-01-25 Issue:4 Volume:192 Page:216-222
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Flentje Michael,Huber Rudolf M.,Engel-Riedel Walburga,Andreas Stefan,Kollmeier Jens,Staar Susanne,Dickgreber Nicolas,Vaissiere Nathalie,De Almeida Cecilia,Edlich Birgit,Fietkau Rainer

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-016-0941-8.pdf

Reference13 articles.

1. Auperin A, Le PC, Rolland E et al (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28:2181–2190

2. Gandara DR, Chansky K, Albain KS et al (2003) Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol 21:2004–2010

3. Kelly K, Chansky K, Gaspar LE et al (2008) Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol 26:2450–2456

4. Hanna N, Neubauer M, Yiannoutsos C et al (2008) Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755–5760

5. Vokes EE, Herndon JE, Crawford J et al (2002) Randomized phase II study of Cisplatin with Gemcitabine or Paclitaxel or Vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer: cancer and Leukemia Group B study 9431. J Clin Oncol 20:4191–4198

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivorship program including long‐term toxicities and quality‐of‐life development over 10 years in a randomized trial in operable stage III non‐small‐cell lung cancer (ESPATUE);International Journal of Cancer;2024-08-28

2. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

3. Online Adaptive Radiotherapy in Pelvic and Thoracic Cancers - Comparing Toxicities, Clinical Outcomes and Technical Parameters between Conventional Image-Guided Radiotherapy and Online Adaptive Radiotherapy – The Study Protocol for the Prospective, Registry-Based, Phase II Trial (PRoART);2024-06-20

4. Anlotinib hydrochloride consolidation after concurrent chemoradiotherapy in stage III non-small-cell lung cancer: a truncated, randomized, multicenter, clinical study (ALTER-L029);Anti-Cancer Drugs;2024-05-03

5. Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer;JAMA Network Open;2024-04-22